New Delhi: India’s drug regulator has audited 49 entities—including online pharmacy warehouses, wholesalers, retailers, and clinics—and issued notices for violations related to unauthorised sale, ...

A fully-featured, console-based Cab Booking System built in Java that demonstrates 15 core Object-Oriented Programming concepts through a real-world ride-hailing simulation. The system covers ...

In India, China and other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

India's semaglutide market has entered a new phase of competition, with prices falling steeply after more than 15 generic versions of the drug were introduced within just two days of patent expiry.

In a shot in the arm for India’s high-growth weight-loss drugs market, generic versions of Danish drugmaker Novo Nordisk’s blockbuster drug semaglutide hit the shelves on Saturday, with price ...

Several generic versions of the popular weight loss drug semaglutide are likely to become available Saturday (March 21) onwards, following the expiry of Novo Nordisk’s patent today. Several of India’s ...

With nearly 50 brands of generic semaglutide set to launch in the Indian market on Saturday, doctors applaud the reduced cost and increased availability of the drug for their patients, along with a ...

The patent for semaglutide, the drug used in major weight-loss medications like Wegovy and Ozempic has expired. The end of the patent — held by Danish pharmaceutical giant Novo Nordisk — opens the ...

Novo Nordisk's India patent on semaglutide expires this week Move to trigger wave of cheaper generics from local drugmakers Concerns raised about misuse, uneven oversight HYDERABAD, March 19 (Reuters) ...

A massive shake-up is underway in India's obesity and diabetes drug market as the patent for Semaglutide—the key ingredient behind blockbuster drugs—expires. This opens the floodgates for over 40 ...

Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...

Kantipuly is a preventive medicine and public health resident at McGill University and visiting scholar at the University of New Mexico. Singer is VK Rajah visiting professor of medical ethics at the ...